12-Minute Walk Test [clinicaltrials_resource:NCT00104234/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
12-Minute Walk Test [clinicaltrials_resource:NCT00104234/outcome/1]
Bio2RDF identifier
NCT00104234/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00104234/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
The efficacy analysis included ...... issed the Week 96 measurement.
The efficacy analysis included ...... issed the Week 96 measurement.
rhASB/rhASB and placebo/rhASB ...... rhASB treatment in each group.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Baseline ASB-03-05 through week 96 of ASB-03-06.
Baseline of ASB-03-05 through week 96 of ASB-03-06
type [clinicaltrials_vocabulary:type]
alternate
12-Minute Walk Test
@en
identifier
clinicaltrials_resource:NCT00104234/outcome/1
title
Mean change in meters walked i ...... culated for Week 96 – Week 24.
@en
type
label
12-Minute Walk Test [clinicaltrials_resource:NCT00104234/outcome/1]
@en